Testing effectiveness (Phase 2)UnknownNCT02397525What this trial is testingAn Open-Label Study to Evaluate Retreatment With LIPO-202Who this might be right forCentral Abdominal Bulging Neothetics, Inc 150
Testing effectiveness (Phase 2)Study completedNCT02568319What this trial is testingSafety and Efficacy Study of LIPO-202 for the Reduction of Central Abdominal Bulging in Obese SubjectsWho this might be right forCentral Abdominal Bulging Neothetics, Inc 120
Large-scale testing (Phase 3)Study completedNCT02398188What this trial is testingEvaluating the Safety and Efficacy of LIPO-202 for the Reduction of Central Abdominal Bulging Due to Subcutaneous Fat (AbCONTOUR2)Who this might be right forCentral Abdominal Bulging Evofem Inc. 793
Large-scale testing (Phase 3)Study completedNCT02397499What this trial is testingEvaluating the Safety and Efficacy of LIPO-202 for the Reduction of Central Abdominal Bulging Due to Subcutaneous FatWho this might be right forCentral Abdominal Bulging Neothetics, Inc 800
Large-scale testing (Phase 3)Ended earlyNCT02483533What this trial is testingExtension Study to Evaluate the Post-Treatment Safety and Duration of Clinical Effect of LIPO-202Who this might be right forCentral Abdominal Bulging Evofem Inc. 100
Not applicableStudy completedNCT01431326What this trial is testingPharmacokinetics of Understudied Drugs Administered to Children Per Standard of CareWho this might be right forAdenovirusAnesthesiaAnxiety+56 more Daniel Benjamin 3,520